Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Berkshire Hathaway Inc. New (BRK-B)

2026-05-04T17:17:31.777458+00:00

Key Updates

Berkshire Hathaway has declined 2.24% to $466.46 since the April 28 report, extending YTD losses to -7.20% and marking the fifth consecutive negative reporting period. The decline follows Greg Abel's first annual shareholder meeting as CEO on May 2, where Q1 2026 results showed strong operational performance with operating earnings rising 18% to $11.35 billion, but the stock continued to underperform the S&P 500 by over 12 percentage points YTD. The company's cash position reached a record $381-397 billion (sources vary), while it resumed share buybacks of $234 million after a year-long hiatus, though this remains modest relative to its cash reserves. Abel's portfolio review signals a strategic shift toward more active capital allocation, designating Apple, American Express, Coca-Cola, and Moody's as core holdings while continuing net stock sales for the 14th consecutive quarter.

Current Trend

BRK-B remains in a sustained downtrend, trading at $466.46 with YTD losses of -7.20% versus the S&P 500's reported 5.6% gain—a 12.8 percentage point underperformance. The stock has declined in five consecutive reporting periods, losing momentum across all timeframes: down 1.38% (1d), 1.34% (5d), 2.28% (1m), 4.35% (6m), and 7.20% YTD. This represents Berkshire's worst relative performance since the tech bubble era, with the price-to-book ratio compressing to approximately 1.4 from 1.8 a year ago. The persistent underperformance reflects investor skepticism about the post-Buffett era, despite strong Q1 operational results. The stock faces technical resistance at recent highs near $477 and appears to be testing support in the mid-$460s range.

Investment Thesis

The investment thesis centers on Berkshire's transformation under Greg Abel's leadership, with the company positioned to deploy its record $381-397 billion cash position opportunistically during market dislocations. Abel's more critical portfolio review approach—designating core holdings and divesting underperformers—represents a strategic evolution from Buffett's indefinite hold philosophy. The company's diversified operating platform delivered 18% operating earnings growth in Q1 2026 to $11.35 billion, driven by insurance, railroad, energy, and manufacturing segments. With 31% of assets in cash and the resumption of buybacks, Berkshire possesses significant dry powder for major acquisitions or minority stakes beyond regulatory insurance requirements. The thesis assumes Abel can leverage Berkshire's permanent capital advantage and insurance float to generate returns comparable to the S&P 500, even if not matching Buffett's historical 19.7% compounded annual gains versus the index's 10.5% from 1965-2025.

Thesis Status

The thesis faces near-term headwinds but retains long-term validity. Q1 2026 results validate the operational strength component, with operating earnings up 18% and net income more than doubling to $10.1 billion. However, the 14th consecutive quarter of net stock sales ($24.1 billion sold vs $15.9 billion purchased) and modest $234 million buyback demonstrate continued capital deployment challenges in an expensive market. The 12.8 percentage point YTD underperformance versus the S&P 500 reflects investor concerns about Abel's ability to replicate Buffett's performance and the removal of the "Buffett premium" from the valuation. The record cash position supports the opportunistic deployment thesis but also highlights the difficulty of finding attractive investments at scale. Abel's portfolio rationalization—identifying core holdings and pruning non-core positions—represents progress toward more active capital management, though execution will determine whether this enhances returns. The 8% discount to intrinsic value estimated by UBS analysts suggests the market is pricing in execution risk during the leadership transition.

Key Drivers

The primary driver is the leadership transition impact, with Abel's first annual meeting revealing investor concerns about replicating Buffett's performance despite his operational expertise. Strong Q1 operational performance provides support, with operating earnings rising 18% to $11.35 billion driven by insurance, railroad, and energy segments. Capital allocation strategy is evolving, as Abel designates Apple, American Express, Coca-Cola, and Moody's as core holdings while reviewing non-core positions. The record cash position of $380 billion provides substantial dry powder for opportunistic deployment, though finding attractive investments at scale remains challenging. Portfolio rationalization continues with expected trimming of Kraft Heinz position and potential changes following Todd Combs' departure. The resumption of $234 million in buybacks signals capital allocation flexibility, though the amount remains modest relative to cash reserves and the estimated 8% discount to intrinsic value.

Technical Analysis

BRK-B at $466.46 shows persistent technical weakness, declining in five consecutive reporting periods with accelerating negative momentum. The stock has broken below the $477 level tested in late April and is testing support in the mid-$460s. Short-term indicators are uniformly negative: down 1.38% (1d), 1.34% (5d), 2.28% (1m), with medium-term deterioration at -4.35% (6m) and -7.20% YTD. The price-to-book ratio compression to 1.4 from 1.8 suggests fundamental de-rating beyond technical factors. Volume patterns around the May 2 annual meeting indicate continued selling pressure despite positive Q1 results. Key resistance now sits at $477 (recent high), with immediate support at current levels around $466. A break below $460 would signal further technical deterioration, while reclaiming $477 would be required to reverse the downtrend. The persistent underperformance versus the S&P 500 (down 7.20% vs up 5.6%) indicates relative weakness that may require catalysts beyond operational performance to reverse.

Bull Case

Bear Case

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.